LifeVantage Director Makes a Significant Stock Sale!

New insider activity at LifeVantage ( (LFVN) ) has taken place on November 21, 2025.TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off Director Michael Beindorff recently sold 12,607 shares of LifeVantage stock, amounting to a total transaction value of $80,810. Recent Updates on LFVN stock In the last 24 hours, LifeVantage Corporation’s stock developments have been influenced by several key factors. The company held its fiscal year 2026 annual meeting, where strategic decisions such as the election of directors and amendments to incentive plans were made. Recent analyst ratings have maintained a Hold position with a price target of $7.00, reflecting a balance between strong financial performance and operational challenges. LifeVantage’s Q1 earnings call highlighted the successful acquisition of LoveBiome, positioning the company for growth in the gut health market. Despite a decline in adjusted EBITDA due to increased costs and seasonal revenue declines, the company remains optimistic about future growth, supported by strategic acquisitions and technological advancements. Analyst Ryan Meyers from Lake Street lowered the price target from $30 to $12, citing a seasonally soft period and tougher year-over-year comparisons, along with a revised revenue outlook and lower valuation multiple. The company’s focus on expanding its wellness ecosystem and strategic initiatives in the gut health segment suggests a promising outlook, despite current challenges. Spark’s Take on LFVN Stock According to Spark, TipRanks’ AI Analyst, LFVN is a Neutral. LifeVantage’s overall stock score reflects a mix of strong financial performance and attractive valuation, offset by bearish technical indicators and some operational challenges highlighted in the earnings call. The company’s strategic initiatives, particularly in the gut health market, provide a positive outlook, but maintaining operational efficiency and addressing cost pressures will be key to future success. To see Spark’s full report on LFVN stock, click here. More about LifeVantage YTD Price Performance: -63.65% Average Trading Volume: 170,287 Technical Sentiment Signal: Sell Current Market Cap: $81.29M